Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Share This

Latest Mizuho News

Intel plummets on earnings

Intel plummets on earnings

January 23, 2026
Mizuho analyst offers his top REIT picks for 2026

Mizuho analyst offers his top REIT picks for 2026

January 20, 2026
Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

January 13, 2026

Mizuho news from around the globe

back-to-top-blue